252 related articles for article (PubMed ID: 31149864)
1. The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantation.
Lehrnbecher T
Expert Rev Anti Infect Ther; 2019 Jul; 17(7):489-499. PubMed ID: 31149864
[No Abstract] [Full Text] [Related]
2. Epidemiology and outcome of invasive fungal disease in children after hematopoietic cell transplantation or treated for malignancy: Impact of national programme of antifungal prophylaxis.
Czyżewski K; Gałązka P; Frączkiewicz J; Salamonowicz M; Szmydki-Baran A; Zając-Spychała O; Gryniewicz-Kwiatkowska O; Zalas-Więcek P; Chełmecka-Wiktorczyk L; Irga-Jaworska N; Bień E; Ociepa T; Wawryków P; Tomaszewska R; Płonowski M; Pierlejewski F; Gamrot-Pyka Z; Małas Z; Urbanek-Dądela A; Stolpa W; Zaucha-Prażmo A; Goździk J; Chaber R; Gil L; Styczyński J
Mycoses; 2019 Nov; 62(11):990-998. PubMed ID: 31429997
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center.
Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH
Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851
[TBL] [Abstract][Full Text] [Related]
5. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation.
Linke C; Ehlert K; Ahlmann M; Fröhlich B; Mohring D; Burkhardt B; Rössig C; Groll AH
Mycoses; 2020 Feb; 63(2):172-180. PubMed ID: 31661569
[TBL] [Abstract][Full Text] [Related]
7. Invasive Fungal Disease Among Pediatric and Adolescent Patients Undergoing Itraconazole Prophylaxis After Hematopoietic Stem Cell Transplantation.
Itsaradisaikul S; Pakakasama S; Boonsathorn S; Techasaensiri C; Rattanasiri S; Apiwattanakul N
Transplant Proc; 2021; 53(6):2021-2028. PubMed ID: 33994183
[TBL] [Abstract][Full Text] [Related]
8. Complications of hematopoietic stem transplantation: Fungal infections.
Omrani AS; Almaghrabi RS
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):239-244. PubMed ID: 28636889
[TBL] [Abstract][Full Text] [Related]
9. Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
Sun Y; Hu J; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
Transpl Infect Dis; 2021 Aug; 23(4):e13611. PubMed ID: 33825274
[TBL] [Abstract][Full Text] [Related]
10. Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.
Liu M; Li Y; Zhang Y; Zhao X; Zhai B; Zhang Q; Wang L; Zhao Y; Li H; Wang Q; Gao C; Huang W; Yu L
PLoS One; 2014; 9(12):e115461. PubMed ID: 25531544
[TBL] [Abstract][Full Text] [Related]
11. Positive results of serum galactomannan assays and pulmonary computed tomography predict the higher response rate of empirical antifungal therapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ji Y; Xu LP; Liu DH; Chen YH; Han W; Zhang XH; Chen H; Wang Y; Wang JZ; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2011 May; 17(5):759-64. PubMed ID: 21056109
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation.
Herity LB; Cruz OA; Aziz MT
J Oncol Pharm Pract; 2022 Jun; 28(4):794-804. PubMed ID: 33906508
[TBL] [Abstract][Full Text] [Related]
13. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
[TBL] [Abstract][Full Text] [Related]
14. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
Olivier-Gougenheim L; Rama N; Dupont D; Saultier P; Leverger G; AbouChahla W; Paillard C; Gandemer V; Theron A; Freycon C; Pluchart C; Blouin P; Pellier I; Thouvenin-Doulet S; Desplantes C; Ducassou S; Oudot C; Rouger-Gaudichon J; Cheikh N; Poiree M; Schneider P; Plat G; Contet A; Rialland F; Gouache E; Brethon B; Bertrand Y; Domenech C
J Pediatr; 2021 Sep; 236():204-210. PubMed ID: 33991540
[TBL] [Abstract][Full Text] [Related]
15. Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
Otto WR; Dvorak CC; Boge CLK; Ostrosky-Zeichner L; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L; Fisher BT
Pediatr Transplant; 2023 Feb; 27(1):e14399. PubMed ID: 36299233
[TBL] [Abstract][Full Text] [Related]
16. Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant.
Zhang X; Zhang L; Li Y; Wang N; Zhang Y
Front Cell Infect Microbiol; 2024; 14():1210857. PubMed ID: 38590441
[TBL] [Abstract][Full Text] [Related]
17. [A clinical analysis of micafungin treatment of pulmonary invasive fungal infection in pediatric patients with acute leukemia or post hematopoietic stem cells transplantation].
Huang K; Qiu KY; Deng LL; Fang JP; Li Y; Guo HX; Zhou DH
Zhonghua Er Ke Za Zhi; 2017 Nov; 55(11):844-847. PubMed ID: 29141316
[No Abstract] [Full Text] [Related]
18. Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.
Fisher BT; Robinson PD; Lehrnbecher T; Steinbach WJ; Zaoutis TE; Phillips B; Sung L
J Pediatric Infect Dis Soc; 2018 Aug; 7(3):191-198. PubMed ID: 28549148
[TBL] [Abstract][Full Text] [Related]
19. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
Kuster S; Stampf S; Gerber B; Baettig V; Weisser M; Gerull S; Medinger M; Passweg J; Schanz U; Garzoni C; Berger C; Chalandon Y; Mueller NJ; van Delden C; Neofytos D; Khanna N;
Transpl Infect Dis; 2018 Dec; 20(6):e12981. PubMed ID: 30144374
[TBL] [Abstract][Full Text] [Related]
20. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH
Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
